EP0699672A1 — Process for preparing benzoic acid derivative intermediates and benzothiophene pharmaceutical agents
Assigned to Eli Lilly and Co · Expires 1996-03-06 · 30y expired
What this patent protects
The present invention provides a novel process for preparing novel compounds of formula I wherein R¹ and R each are independently C₁-C₄ alkyl, or combine to form piperidinyl, pyrrolidinyl, methylpyrrolidinyl, dimethylpyrrolidinyl, morpholino, dimethylamino, diethylam…
USPTO Abstract
The present invention provides a novel process for preparing novel compounds of formula I wherein R¹ and R each are independently C₁-C₄ alkyl, or combine to form piperidinyl, pyrrolidinyl, methylpyrrolidinyl, dimethylpyrrolidinyl, morpholino, dimethylamino, diethylamino, or 1-hexamethyleneimino; and n is 2 or 3; or a pharmaceutically acceptable salt thereof, comprising a) reacting a haloalkyl amine of formula III wherein X is a halogen; and R¹, R, and n are as defined above, with a compound of formula IV wherein R is C₁-C₆ alkyl, in the presence of an alkyl acetate solvent and a base; b) extracting the reaction product of step a) with an aqueous acid; and c) cleaving the ester of the reaction product from step b) to form an acid. The present invention further provides a novel process for preparing compounds of formula V wherein R¹ and R each are independently C₁-C₄ alkyl, or combine to form piperidinyl, pyrrolidino, methylpyrrolidino, dimethylpyrrolidinyl, morpholino, dimethylamino, diethylamino, or 1-hexamethyleneimino; R³ and R⁴ each are H or a hydroxy protecting group; and n is 2 or 3; or a pharmaceutically acceptable salt thereof, comprising a) reacting a haloalkyl amine of formula III wherein X is a halogen; and R¹, R, and n are as defined above, with a compound of formula IV wherein R is C₁-C₆ alkyl, in the presence of an alkyl acetate solvent and a base; b) extracting the reaction product from step a) with an aqueous acid; c) cleaving the ester of the reaction product from step b) to form an acid; d) reacting the extracted product from step c) with a compound of formula V wherein R³ and R⁴ are as defined above, or a pharmaceutically acceptable salt thereof; e) optionally removing the R³ and R⁴ hydroxy protecting groups of the reaction product form step d); and f) optionally forming a salt of the reaction product from either steps d) or step e).
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.